Wyeth has announced a shortage of Phospholine Iodide (echothiophate iodide ophthalmic solution 0.125%) due to a delay in supplies of this product’s raw materials. Wyeth is initiating a limited distribution plan for purchases and limiting sales to one bottle per patient for current patients only.
Phospholine Iodide is indicated for the treatment of glaucoma and accommodative esotropia.
For more information call (800) 666-7248 or visit www.wyeth.com.
Related Content